Abstract
Pioneering studies both in humans and animals have demonstrated an association between the peripheral nervous system and epidermal melanocyte destruction. The presence of certain neuropeptides and neuronal structural markers in peripheral nerve fibres was investigated in involved and uninvolved vitiligo skin and compared with normal healthy skin. A group of 18 vitiligo vulgaris patients and matched healthy volunteers participated in the investigation. The indirect immunofluorescence technique was employed. There was a tendency for a reduction in the number and intensity of low affinity (p75) nerve growth factor receptor immunoreactive (NGFr-IR) basal keratinocytes in involved vitiliginous skin (P<0.06) compared with control skin, while the number of NGFr-IR nerve fibres was significantly increased (P<0.01). The number of calcitonin gene-related peptide (CGRP)-IR nerve fibres in the epidermis and papillary dermis was dramatically increased in involved skin as compared with control skin (P<0.01) and with uninvolved skin (P<0.05). No clear difference could be found in the distribution of vasoactive intestinal polypeptide (VIP)-and neuropeptide tyrosine (NPY)-IR nerve fibres. A different structural appearance of the peripheral nervous system as well as a changed balance of neuropeptides in vitiliginous skin point to a critical role of the nervous system in the pathogenesis of vitiligo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mosher DB, Fitzpatrick TB, Hori Y, Ortonne J-P (1993) Disorders of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine, 4th edn, vol I. McGraw-Hill, New York, pp 903–995
Koplon BS, Shapiro L (1968) Poliosis overlying a neurofibroma. Arch Dermatol 98:631–633
Zvulunov A, Esterly NB (1995) Neurocutaneous syndromes associated with pigmentary skin lesions. J Am Acad Dermatol 32:915–935
Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97:255–261
Lerner AB (1959) Vitiligo, J Invest Dermatol 32:285–310
Arnozan L (1992) Vitiligo avec troubles nerveux sensitifs et sympathetiques: l’origine sympathique du vitiligo. Bull Soc Fr Dermatol Syphiligr 29:338–342
Nellhaus G (1970) Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology 20:965–974
Spencer GA, Tolmach JA (1952) Exchange grafts in vitiligo. J Invest Dermatol 19:1–5
Lerner AB, Snell RS, Chanco-Turner ML, McGuire JS (1966) Vitiligo and sympathectomy: Arch Dermatol 94:269–278
Liu P-Y, Löntz W, Bondesson L, Johansson O (1995) The possible role of α-, β- and γ3-melanocyte stimulating hormone-containing keratinocytes in the initiation of vitiligo vulgaris. Eur J Dermatol 5:625–630
McBurney EI (1979) Vitiligo, Clinical picture and pathogenesis. Arch Intern Med 139:1295–1297
Fábián G (1951) Spread of black pigment on the denervated skin of guinea pigs. Acta Biol Acad Sci 4:471–479
Johansson O, Nordlind K (1984) Immunohistochemical localization of somatostatin-like immunoreactivity in skin lesions from patients with urticaria pigmentosa. Virchows Arch [B] 46: 155–164
Johansson O (1985) Morphological characterization of the somatostatin-immunoreactive dendritic skin cells in urticaria pigmentosa patients by computerized image analysis. Scand J Immunol 21:431–439
Johnson EM Jr, Gorin PD, Brandeis LD, Pearson J (1980) Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210:916–918
Levi-Montalcini R, Angeletti PU (1968) Nerve growth factor Physiol Rev 48:534–569
Yaar M, Grossman K, Eller M, Gilchrest BA (1991) Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 115:821–828
Le Poole IC, Wijngaard RMJGJ van den, Westerhof W, Dutrieux RP, Das PK (1993) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100: 816–822
Ribeiro-da-Silva A, Kenigsberg RL, Cuello AC (1991) Light and electron microscopic distribution of nerve growth factor receptor-like immunoreactivity in the skin of the rat lower lip. Neuroscience 43: 631–646
Breathnach AS, Bor S, Wyllie LM-A (1966) Electron microscopy of peripheral nerve terminals and marginal melanocytes in vitiligo. J Invest Dermatol 47: 125–140
Morohashi M, Hashimoto K, Goodman TF Jr, Newton DE, Rist T (1977) Ultrastructural studies of vitiligo, Vogt-Koyanagi syndrome, and incontinentia pigmenti achromians. Arch Dermatol 113: 755–766
Al’Abadic MSK, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 131: 160–165
Chanco-Turner ML, Lerner AB (1965) Physiologic changes in vitiligo. Arch Dermatol 91: 390–396
Morrone A, Picardo M, Luca CD, Terminali O, Passi S, Ippolito F (1992) Catecholamines and vitiligo. Pigment Cell Res 5: 65–69
Mozzanica N, Villa ML, Foppa S, Vignati G, Cattanco A, Diotti R, Finzi AF (1992) Plasma α-melanocyte-stimulating hormone, β-endorphin, met-enkephalin, and natural killer cell activity in vitiligo. J Am Acad Dermatol 26: 693–700
Maggi CA (1991) Capsaicin and primary afferent neurons: from basic science to human therapy? J Auton Nerv Syst 33: 1–14
Laties AM, Lerner AB (1975) Iris colour and relationship of tyrosinase activity to adrenergic innervation. Nature 255: 152–153
Kawauchi H, Naito N, Ono M (1993) Chemistry of melaninconcentrating hormone. Ann NY Acad Sci 680: 64–77
Author information
Authors and Affiliations
Additional information
Work was supported by funds from the Medical Faculty of the Karolinska Institute
Rights and permissions
About this article
Cite this article
Liu, P.Y., Bondesson, L., Löntz, W. et al. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study. Arch Dermatol Res 288, 670–675 (1996). https://doi.org/10.1007/BF02505276
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505276